Cancer drugs for cheap! And the implications?
Posted by evolvingwheel on January 24, 2007
New Scientist reported a new finding which could be a breakthrough in cheap but potent treatments for cancer. The finding comes from a recent research conducted by Evangelos Michelakis and his colleagues at the University of Alberta in Edmonton, Canada. You may refer to the main article here.
One interesting fact is that the drug found to be having an extremely positive impact on different cancer cells is dichloroacetate (DCA) – a non-patented and long-prescribed affordable drug. The clinical trials of DCA may not be sponsored by big pharmas since there wont be any profit on non-patented drugs. So charities, nonprofits, universities, and governmental research centers will possibly chip in. Now what if this is a trend? What if hundreds of research centers in universities and govt. organizations across the country (or say the entire world) come up with breakthroughs in medicinal developments outside the realm of big pharma funded projects? How does the product get to the market successfully? Who markets it? Will governments provide subsidies in trials, capital investments, mass production, marketing, and eventual launching in the global pharmaceutical market? Now, we do know how bureaucratic things get when government processes are used to deliver time-critical and highly sophisticated products 😉
So who will step forward with sound management skills, marketing horsepower, and highly organized processes and operations? Startups? Nonprofits? But nonprofits are not yet well equipped with that level of management that we see in big corporations who pay a fortune for the big guns! And what’s the return even if someone chimes in? How will we integrate social innovation with technological innovation while having a margin enough to sustain the investments?………